Aceto Corp (ACET) 20.00 $ACET
2015 New-Year Coverage Universe Updates
DAG Investments - at Seeking Alpha - Thu Feb 12, 9:10AM CST
ACET: 20.00 (+0.27), GE: 25.15 (+0.26), KR: 72.86 (+0.41), BX: 37.40 (+0.49), CCLP: 16.61 (+0.44), CECE: 14.70 (+0.23), PFE: 34.64 (-0.23), HAL: 44.19 (+1.42), SPWR: 28.30 (+0.07), HLS: 45.01 (+0.30), MTW: 21.86 (+0.34), AET: 96.12 (-0.96), MWA: 9.19 (+0.09), VLO: 58.60 (+2.05), FSLR: 48.84 (-0.58), WBA: 78.73 (-1.23), RJF: 57.05 (-0.36), TRN: 29.79 (+0.33), CWCO: 10.62 (-0.02), WMB: 49.41 (+1.44), ANAC: 40.76 (-0.07), SXI: 71.53 (-0.23), IHG: 40.34 (-1.03)
Aceto's (ACET) CEO Salvatore Guccione on Q2 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Feb 06, 11:42AM CST
ACET: 20.00 (+0.27)
Aceto beats by $0.02, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Feb 05, 4:04PM CST
ACET: 20.00 (+0.27)
ACETO Reports Second Quarter Fiscal 2015 Results
GlobeNewswire - Thu Feb 05, 4:00PM CST
ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the second quarter of fiscal 2015 ended December 31, 2014.
ACET: 20.00 (+0.27)
Aceto declares $0.06 dividend
Seeking Alpha - at Seeking Alpha - Thu Feb 05, 2:40PM CST
ACET: 20.00 (+0.27)
ACETO Board of Directors Declares Quarterly Cash Dividend
GlobeNewswire - Thu Feb 05, 2:34PM CST
ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that its Board of Directors has declared a regular quarterly dividend of $0.06 per common share. This quarterly cash dividend will be distributed on March 26, 2015 to shareholders of record as of March 12, 2015.
ACET: 20.00 (+0.27)
Notable earnings after Thursday’s close
Seeking Alpha - at Seeking Alpha - Wed Feb 04, 4:35PM CST
BEBE: 3.90 (+0.01), ACET: 20.00 (+0.27), ARCW: 6.62 (+0.23), CPST: 0.73 (+0.03), AIV: 38.55 (-0.50), DV: 36.69 (+0.04), EGAN: 3.78 (+0.08), CUTR: 11.94 (-0.21), MTD: 307.00 (-0.13), PXLW: 5.24 (-0.22), LNKD: 269.00 (+1.83), ADNC: 4.59 (-0.02), LGF: 32.17 (+0.08), AHL: 46.44 (-0.29), HME: 67.76 (-0.96), PDFS: 18.31 (+0.04), MCK: 224.89 (+0.12), KRG: 29.17 (+0.23), ATHN: 134.60 (+4.95), PCTY: 28.59 (+0.38), BRS: 61.71 (+3.65), ECOM: 9.69 (+0.63), FWM: 5.55 (+0.08), EXPE: 89.49 (-0.08), NTGR: 31.63 (+0.23), IMPV: 43.17 (+1.38), OLN: 27.31 (+0.13), MRIN: 7.04 (+0.04), BWLD: 187.27 (+0.30), ASYS: 9.87 (+0.30), DCT: 36.70 (+0.23), BCOV: 8.43 (+0.27), MXWL: 6.47 (+0.07), CME: 93.92 (-1.39), ATVI: 23.11 (+0.17), KIM: 26.83 (-0.25), P: 15.44 (+0.45), BMI: 60.09 (+0.56), OUTR: 68.39 (+2.22), CTRL: 13.39 (+0.10), GPRO: 45.27 (-0.02), ECHO: 26.72 (+0.35), RDEN: 16.59 (+0.90), NUAN: 14.26 (+0.20), ATR: 64.56 (+0.49), ACLS: 2.81 (+0.04), EGOV: 16.20 (+0.30), PDM: 18.79 (-0.15), FLDM: 37.93 (-0.47), BRKS: 12.08 (+0.04), FLT: 150.37 (+1.15), ASEI: 56.82 (+0.30), ENH: 64.63 (+0.15), CALD: 14.95 (+0.03), ONNN: 11.94 (+0.33), LF: 2.51 (+0.06)
Commit To Purchase Aceto Corp. At $17.50, Earn 9.7% Annualized Using Options
at The Street - Thu Jan 29, 10:38AM CST
Investors eyeing a purchase of Aceto Corp. stock, but cautious about paying the going market price of $19.89/share, might benefit from considering selling puts among the alternative strategies at their disposal.
ACET: 20.00 (+0.27)
ACETO Corporation Schedules Second Quarter Fiscal 2015 Financial Results News Release and Conference Call
GlobeNewswire - Mon Jan 26, 9:03AM CST
ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, will issue its financial results of operations for the second quarter of fiscal 2015 ended December 31, 2014 after the stock market close on Thursday, February 5, 2015.
ACET: 20.00 (+0.27)
United States Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry Analytics 2014-2021 - Market to reach $21.2 billion by 2021
M2 - Mon Dec 15, 8:28AM CST
Research and Markets (http://www.researchandmarkets.com/research/b7xlml/vitamins) has announced the addition of Plunkett Research Ltd's new report "Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021" to their offering. Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry (U.S.) to reach $21.2 billion by 2021. Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Core Benefits to Customer: 1. Comprehensive overview of an industry's financial results, ratios, vital statistics and metrics in one package 2. Complete benchmarking of the industry and its top companies 3. Deep industry and company financials This Report Features: 1. Historical data 2. Revenue forecasts, growth rates and CAGR 3. Operating ratios 4. Complete data for benchmarking a company to its industry and to specific leading companies 5. Benchmarking this industry to all U.S. industries 6. Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies Designed to benefit: - Analysis and Financial Modeling - Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants Key Data: Industry Summary - Revenues historical through 2013 - Revenues projected through 2021 - Employee Count 2007-2013 - Annual Growth Rate 2013 - CAGR 2006 through 2013 - CAGR 2014 through 2021 - Top U.S. Companies Employment and Establishments - Number of Firms 2007-2013 - Number of Establishments 2007-2013 - Employees, 2007-2013 - Average Annual Sales per Firm & per Establishment 2007-2013 - Sales per Employee Average Annual Operating Ratios - Revenue Compared to All Industries - Expenses Compared to All Industries - Profits & Income Taxes Compared to All Industries Benchmarks This Industry Compared to All Industries - Comparison of Revenues, Profits and Taxes to All Industries Industry Results, Publicly-Held Companies (U.S.), Average for all Companies - Industry Income Statement, Balance Sheet, Cash Flow Statement, 2008-2013 Top Companies Profiled & Ranked In-Depth Profiles, Financial Reports, Ranks & Executive Lists for Top U.S.-Based Corporations Top Companies Ranked - Market Capitalization - Employees - Revenue - Net Income - 3-Year Revenue Growth - 3-Year Income Growth - Return on Assets - Return on Equity - Return on Invested Capital List of Leading (Public and Private) Companies - Aceto Corporation - Balchem Corp - Cambrex Corp - Mannatech Inc - Mead Johnson Nutrition Company - NBTY Inc - Schiff Nutrition International Inc - Sigma-Aldrich Corp - Synutra International, Inc. - USANA Health Sciences Inc For more information visit http://www.researchandmarkets.com/research/b7xlml/vitamins Source: Plunkett Research Ltd
ACET: 20.00 (+0.27), MJN: 101.89 (+2.32), CBM: 32.96 (+0.09), SIAL: 138.20 (+0.07), USNA: 101.37 (+0.53), SYUT: 5.29 (unch), MTEX: 23.89 (+0.69), BCPC: 58.18 (+0.84)
Insider Trading Alert - GLT, NEWT And ACET Traded By Insiders
at The Street - Fri Dec 12, 10:00AM CST
Stocks with insider trader activity include GLT, NEWT and ACET
ACET: 20.00 (+0.27), NEWT: 15.13 (-0.12), GLT: 24.89 (+0.04)
Update: Aceto Corporation SIC Code Change
DAG1996 - at Seeking Alpha - Wed Dec 10, 12:16AM CST
ACET: 20.00 (+0.27)
Aceto Corporation declares $0.06 dividend
Seeking Alpha - at Seeking Alpha - Thu Dec 04, 4:01PM CST
ACET: 20.00 (+0.27)
ACETO Receives SEC Approval to Change its SIC Code to 5122
GlobeNewswire - Thu Dec 04, 10:52AM CST
ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that the Securities and Exchange Commission has approved the Company's request to change its SIC code from 5160, Wholesale - Chemicals and Allied Products, to 5122, Wholesale- Drugs, Proprietaries and Druggists' Sundries, effective immediately.
ACET: 20.00 (+0.27)
Insider Trading Alert - ACET, VG And RIBT Traded By Insiders
at The Street - Wed Dec 03, 10:30AM CST
Stocks with insider trader activity include ACET, VG and RIBT
ACET: 20.00 (+0.27), RIBT: 4.01 (-0.02), VG: 4.37 (+0.02)
Stocks to watch ahead of the "Best of the Uncovereds" conference
Seeking Alpha - at Seeking Alpha - Wed Nov 19, 6:45AM CST
ACET: 20.00 (+0.27), ACU: 18.70 (unch), BONE: 3.09 (+0.09), MNTX: 11.54 (+0.10), TREC: 14.54 (+0.20), INTL: 23.43 (+0.46), HPJ: 5.71 (+0.16), SPA: 22.31 (-0.02), AXPW: 0.39 (-0.04), DXPE: 46.57 (+1.42), LODE: 0.84 (unch), LABL: 63.28 (+0.85), NEWT: 15.13 (-0.12), SA: 8.08 (+0.04), PSEC: 8.67 (+0.07)
ACETO to Present at Two Upcoming Investment Conferences
GlobeNewswire - Fri Nov 14, 7:01AM CST
ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that senior management will present at two upcoming investment conferences on Thursday November 20, 2014 in New York City.
ACET: 20.00 (+0.27)
Aceto Corporation's (ACET) CEO Salvatore Guccione on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Nov 07, 5:41PM CST
ACET: 20.00 (+0.27)
ACETO Reports Fiscal 2015 First Quarter Results
GlobeNewswire - Thu Nov 06, 4:17PM CST
ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the first quarter of fiscal 2015 ended September 30, 2014.
ACET: 20.00 (+0.27)
2015 New-Year Coverage Universe Updates
DAG Investments - at Seeking Alpha - Thu Feb 12, 9:10AM CST
ACET: 20.00 (+0.27), GE: 25.15 (+0.26), KR: 72.86 (+0.41), BX: 37.40 (+0.49), CCLP: 16.61 (+0.44), CECE: 14.70 (+0.23), PFE: 34.64 (-0.23), HAL: 44.19 (+1.42), SPWR: 28.30 (+0.07), HLS: 45.01 (+0.30), MTW: 21.86 (+0.34), AET: 96.12 (-0.96), MWA: 9.19 (+0.09), VLO: 58.60 (+2.05), FSLR: 48.84 (-0.58), WBA: 78.73 (-1.23), RJF: 57.05 (-0.36), TRN: 29.79 (+0.33), CWCO: 10.62 (-0.02), WMB: 49.41 (+1.44), ANAC: 40.76 (-0.07), SXI: 71.53 (-0.23), IHG: 40.34 (-1.03)
Aceto's (ACET) CEO Salvatore Guccione on Q2 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Feb 06, 11:42AM CST
ACET: 20.00 (+0.27)
Aceto beats by $0.02, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Feb 05, 4:04PM CST
ACET: 20.00 (+0.27)
ACETO Reports Second Quarter Fiscal 2015 Results
GlobeNewswire - Thu Feb 05, 4:00PM CST
ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the second quarter of fiscal 2015 ended December 31, 2014.
ACET: 20.00 (+0.27)
Aceto declares $0.06 dividend
Seeking Alpha - at Seeking Alpha - Thu Feb 05, 2:40PM CST
ACET: 20.00 (+0.27)
ACETO Board of Directors Declares Quarterly Cash Dividend
GlobeNewswire - Thu Feb 05, 2:34PM CST
ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that its Board of Directors has declared a regular quarterly dividend of $0.06 per common share. This quarterly cash dividend will be distributed on March 26, 2015 to shareholders of record as of March 12, 2015.
ACET: 20.00 (+0.27)
Notable earnings after Thursday’s close
Seeking Alpha - at Seeking Alpha - Wed Feb 04, 4:35PM CST
BEBE: 3.90 (+0.01), ACET: 20.00 (+0.27), ARCW: 6.62 (+0.23), CPST: 0.73 (+0.03), AIV: 38.55 (-0.50), DV: 36.69 (+0.04), EGAN: 3.78 (+0.08), CUTR: 11.94 (-0.21), MTD: 307.00 (-0.13), PXLW: 5.24 (-0.22), LNKD: 269.00 (+1.83), ADNC: 4.59 (-0.02), LGF: 32.17 (+0.08), AHL: 46.44 (-0.29), HME: 67.76 (-0.96), PDFS: 18.31 (+0.04), MCK: 224.89 (+0.12), KRG: 29.17 (+0.23), ATHN: 134.60 (+4.95), PCTY: 28.59 (+0.38), BRS: 61.71 (+3.65), ECOM: 9.69 (+0.63), FWM: 5.55 (+0.08), EXPE: 89.49 (-0.08), NTGR: 31.63 (+0.23), IMPV: 43.17 (+1.38), OLN: 27.31 (+0.13), MRIN: 7.04 (+0.04), BWLD: 187.27 (+0.30), ASYS: 9.87 (+0.30), DCT: 36.70 (+0.23), BCOV: 8.43 (+0.27), MXWL: 6.47 (+0.07), CME: 93.92 (-1.39), ATVI: 23.11 (+0.17), KIM: 26.83 (-0.25), P: 15.44 (+0.45), BMI: 60.09 (+0.56), OUTR: 68.39 (+2.22), CTRL: 13.39 (+0.10), GPRO: 45.27 (-0.02), ECHO: 26.72 (+0.35), RDEN: 16.59 (+0.90), NUAN: 14.26 (+0.20), ATR: 64.56 (+0.49), ACLS: 2.81 (+0.04), EGOV: 16.20 (+0.30), PDM: 18.79 (-0.15), FLDM: 37.93 (-0.47), BRKS: 12.08 (+0.04), FLT: 150.37 (+1.15), ASEI: 56.82 (+0.30), ENH: 64.63 (+0.15), CALD: 14.95 (+0.03), ONNN: 11.94 (+0.33), LF: 2.51 (+0.06)
Commit To Purchase Aceto Corp. At $17.50, Earn 9.7% Annualized Using Options
at The Street - Thu Jan 29, 10:38AM CST
Investors eyeing a purchase of Aceto Corp. stock, but cautious about paying the going market price of $19.89/share, might benefit from considering selling puts among the alternative strategies at their disposal.
ACET: 20.00 (+0.27)
ACETO Corporation Schedules Second Quarter Fiscal 2015 Financial Results News Release and Conference Call
GlobeNewswire - Mon Jan 26, 9:03AM CST
ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, will issue its financial results of operations for the second quarter of fiscal 2015 ended December 31, 2014 after the stock market close on Thursday, February 5, 2015.
ACET: 20.00 (+0.27)
United States Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry Analytics 2014-2021 - Market to reach $21.2 billion by 2021
M2 - Mon Dec 15, 8:28AM CST
Research and Markets (http://www.researchandmarkets.com/research/b7xlml/vitamins) has announced the addition of Plunkett Research Ltd's new report "Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021" to their offering. Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry (U.S.) to reach $21.2 billion by 2021. Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Core Benefits to Customer: 1. Comprehensive overview of an industry's financial results, ratios, vital statistics and metrics in one package 2. Complete benchmarking of the industry and its top companies 3. Deep industry and company financials This Report Features: 1. Historical data 2. Revenue forecasts, growth rates and CAGR 3. Operating ratios 4. Complete data for benchmarking a company to its industry and to specific leading companies 5. Benchmarking this industry to all U.S. industries 6. Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies Designed to benefit: - Analysis and Financial Modeling - Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants Key Data: Industry Summary - Revenues historical through 2013 - Revenues projected through 2021 - Employee Count 2007-2013 - Annual Growth Rate 2013 - CAGR 2006 through 2013 - CAGR 2014 through 2021 - Top U.S. Companies Employment and Establishments - Number of Firms 2007-2013 - Number of Establishments 2007-2013 - Employees, 2007-2013 - Average Annual Sales per Firm & per Establishment 2007-2013 - Sales per Employee Average Annual Operating Ratios - Revenue Compared to All Industries - Expenses Compared to All Industries - Profits & Income Taxes Compared to All Industries Benchmarks This Industry Compared to All Industries - Comparison of Revenues, Profits and Taxes to All Industries Industry Results, Publicly-Held Companies (U.S.), Average for all Companies - Industry Income Statement, Balance Sheet, Cash Flow Statement, 2008-2013 Top Companies Profiled & Ranked In-Depth Profiles, Financial Reports, Ranks & Executive Lists for Top U.S.-Based Corporations Top Companies Ranked - Market Capitalization - Employees - Revenue - Net Income - 3-Year Revenue Growth - 3-Year Income Growth - Return on Assets - Return on Equity - Return on Invested Capital List of Leading (Public and Private) Companies - Aceto Corporation - Balchem Corp - Cambrex Corp - Mannatech Inc - Mead Johnson Nutrition Company - NBTY Inc - Schiff Nutrition International Inc - Sigma-Aldrich Corp - Synutra International, Inc. - USANA Health Sciences Inc For more information visit http://www.researchandmarkets.com/research/b7xlml/vitamins Source: Plunkett Research Ltd
ACET: 20.00 (+0.27), MJN: 101.89 (+2.32), CBM: 32.96 (+0.09), SIAL: 138.20 (+0.07), USNA: 101.37 (+0.53), SYUT: 5.29 (unch), MTEX: 23.89 (+0.69), BCPC: 58.18 (+0.84)
Insider Trading Alert - GLT, NEWT And ACET Traded By Insiders
at The Street - Fri Dec 12, 10:00AM CST
Stocks with insider trader activity include GLT, NEWT and ACET
ACET: 20.00 (+0.27), NEWT: 15.13 (-0.12), GLT: 24.89 (+0.04)
Update: Aceto Corporation SIC Code Change
DAG1996 - at Seeking Alpha - Wed Dec 10, 12:16AM CST
ACET: 20.00 (+0.27)
Aceto Corporation declares $0.06 dividend
Seeking Alpha - at Seeking Alpha - Thu Dec 04, 4:01PM CST
ACET: 20.00 (+0.27)
ACETO Receives SEC Approval to Change its SIC Code to 5122
GlobeNewswire - Thu Dec 04, 10:52AM CST
ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that the Securities and Exchange Commission has approved the Company's request to change its SIC code from 5160, Wholesale - Chemicals and Allied Products, to 5122, Wholesale- Drugs, Proprietaries and Druggists' Sundries, effective immediately.
ACET: 20.00 (+0.27)
Insider Trading Alert - ACET, VG And RIBT Traded By Insiders
at The Street - Wed Dec 03, 10:30AM CST
Stocks with insider trader activity include ACET, VG and RIBT
ACET: 20.00 (+0.27), RIBT: 4.01 (-0.02), VG: 4.37 (+0.02)
Stocks to watch ahead of the "Best of the Uncovereds" conference
Seeking Alpha - at Seeking Alpha - Wed Nov 19, 6:45AM CST
ACET: 20.00 (+0.27), ACU: 18.70 (unch), BONE: 3.09 (+0.09), MNTX: 11.54 (+0.10), TREC: 14.54 (+0.20), INTL: 23.43 (+0.46), HPJ: 5.71 (+0.16), SPA: 22.31 (-0.02), AXPW: 0.39 (-0.04), DXPE: 46.57 (+1.42), LODE: 0.84 (unch), LABL: 63.28 (+0.85), NEWT: 15.13 (-0.12), SA: 8.08 (+0.04), PSEC: 8.67 (+0.07)
ACETO to Present at Two Upcoming Investment Conferences
GlobeNewswire - Fri Nov 14, 7:01AM CST
ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that senior management will present at two upcoming investment conferences on Thursday November 20, 2014 in New York City.
ACET: 20.00 (+0.27)
Aceto Corporation's (ACET) CEO Salvatore Guccione on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Nov 07, 5:41PM CST
ACET: 20.00 (+0.27)
ACETO Reports Fiscal 2015 First Quarter Results
GlobeNewswire - Thu Nov 06, 4:17PM CST
ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the first quarter of fiscal 2015 ended September 30, 2014.
ACET: 20.00 (+0.27)
